Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

AstraZeneca’s Fasenra receives FDA approval to treat rare inflammatory disease EGPA

Eosinophilic granulomatosis with polyangiitis affects approximately 15,000 people in the US

- PMLiVE

Merck’s Keytruda approved by FDA as first-line malignant pleural mesothelioma treatment

More than 30,000 new cases of mesothelioma were diagnosed globally in 2022

Daiichi Sankyo logo

Daiichi Sankyo’s Vanflyta recommended by NICE for acute myeloid leukaemia

Approximately 18,000 cases of the blood cancer are diagnosed every year in Europe

- PMLiVE

Digital biomarkers: reinventing patient monitoring and care

By Polina Zayakina and Urs Wiedemann

- PMLiVE

Novartis’ Kisqali combination granted FDA approval for early breast cancer patients

The drug is already approved for certain cases of advanced or metastatic breast cancer

- PMLiVE

J&J’s Rybrevant combination shows positive overall survival trend in late-stage lung cancer study

Alterations in EGFR are among the most common driver mutations in NSCLC patients

- PMLiVE

Merck presents positive phase 3 results for Keytruda regimen in early-stage breast cancer

Approximately 56,800 new cases of breast cancer are diagnosed in the UK every year

- PMLiVE

Innovation and flexibility in long-term follow-up studies

By Harpreet Gill

- PMLiVE

Realizing the Potential of Virtual Patient Simulation With Real-World Outcomes

We're celebrating Healthcare Simulation Week 2024 by highlighting the transformative power of our multi-award-winning medical simulation programs, which have proven impact in delivering significant improvements in clinical skills and outcomes....

Medscape Education

- PMLiVE

Reaching Young Professionals at HFSA ASM 2024

HFSA will kick off at the end of September, and Medscape is proud to support the careers of young clinicians through the sponsorship of the Professionals in Training Lounge. “Providing...

Medscape Education

- PMLiVE

Evolving market access pathways for AI-enabled Medtech in Europe

Louise Maddison (Senior Consultant – Global Market Access, Mtech Access) explores the evolving market access landscape for AI-enabled Medtech, with a particular focus on the key European markets of France,...

Petauri Evidence

- PMLiVE

Roche’s injectable Ocrevus Zunovo granted FDA approval to treat relapsing and primary MS

The subcutaneous formulation has the same twice-yearly dosing schedule as the previously approved intravenous infusion

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links